Indication
Myocardial Infarction
Aliases
Myocardial Infarct
53 clinical trials
63 products
5 drugs
Product
Hearticellgram-AMIClinical trial
A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarctionStatus: Active (not recruiting), Estimated PCD: 2024-10-31
Clinical trial
A Retrospective Phase IIa Study of Intravenous Allogeneic Non-HLA-Matched, Unrelated Donor Stem Cell, MiSaver (Myocardial Infarction Saver), Infusion for Recent Acute Myocardial InfarctionStatus: Completed, Estimated PCD: 2023-12-31
Product
MiSaverProduct
PlaceboClinical trial
Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Self-administered Subcutaneous Selatogrel for Prevention of All-cause Death and Treatment of Acute Myocardial Infarction in Subjects With a Recent History of Acute Myocardial InfarctionStatus: , Estimated PCD: 2025-08-01
Product
SelatogrelClinical trial
EXpanded CELL ENdocardiac Transplantation (EXCELLENT)Status: Completed, Estimated PCD: 2024-03-15
Product
PROTHERACYTESProduct
Middle DoseClinical trial
Efficacy and Safety of Recombinant Human Thymosin β4(NL005) for Injection in Patients With Acute Myocardial Infarction: a Phase IIb Clinical StudyStatus: Completed, Estimated PCD: 2023-05-26
Product
Ammonia N-13Product
FDY-5301Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Intravenous FDY 5301 in Patients With an Anterior ST-Elevation Myocardial InfarctionStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by Positron Emission Tomography in Patients With Known or Suspected Coronary Artery Disease (Ammonia MAP)Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel Group, Dose-finding Phase 2 Study to Evaluate the Efficacy and Safety of BAY 2433334 in Patients Following an Acute Myocardial InfarctionStatus: Completed, Estimated PCD: 2022-02-21
Clinical trial
Multicentre, Open-label, Non-interventional Observational Clinical Study Lasting 48 Weeks in Patients With Heart Failure or Reduced Left Ventricular Ejection Fraction Following Acute Myocardial Infarction Who Are Treated With CarvedilolStatus: Completed, Estimated PCD: 2011-11-01
Product
CarvedilolProduct
BAY2433334Product
High DoseProduct
AsundexianProduct
LCZ696Product
RamiprilClinical trial
A Multi-center, Randomized, Double-blind, Active-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Ramipril on Morbidity and Mortality in High Risk Patients Following an Acute Myocardial Infarction (AMI)Status: Completed, Estimated PCD: 2021-02-26
Product
ValsartanClinical trial
Investigation of the Influence of Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Asundexian in Participants With Mild or Moderate Hepatic Impairment Compared to Participants With Normal Hepatic Function.Status: Completed, Estimated PCD: 2023-05-24
Clinical trial
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)Status: Completed, Estimated PCD: 2015-02-01
Product
Placebo + AspirinProduct
DapagliflozinClinical trial
A Registry-based, Randomised, Double-blind, Placebo-Controlled Cardiovascular Outcomes Trial to Evaluate the Effect of Dapagliflozin on Cardiometabolic Outcomes in Patients Without Diabetes With Acute Myocardial Infarction at Increased Risk for Subsequent Development of Heart FailureStatus: Completed, Estimated PCD: 2023-07-05
Clinical trial
A Multi-center, Open-label, Randomized, Study to Assess the Onset of Platelet Aggregation Inhibition After a Single Subcutaneous Injection of ACT-246475 in Adults With Acute Myocardial InfarctionStatus: Completed, Estimated PCD: 2018-11-10
Product
PexelizumabClinical trial
APEX-AMI - Pexelizumab in Conjunction With AngioplastyStatus: Completed, Estimated PCD: 2007-05-01
Clinical trial
An Open-label, Single-dose, Safety and Pharmacokinetic Study of Regadenoson in Pediatric PatientsStatus: Recruiting, Estimated PCD: 2024-08-01
Product
RegadenosonClinical trial
Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular Outcomes (mTECH-Rehab): A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Investigator-initiated, Randomized, Double-blind, Controlled, Multi-center Trial of Intravenous Iron in Patients With Cardiovascular Disease and Concomitant Iron DeficiencyStatus: Terminated, Estimated PCD: 2021-12-15
Product
Ferric carboxymaltoseProduct
SalineClinical trial
Early Glycoprotein IIb/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients With Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS)Status: Completed, Estimated PCD: 2008-11-01
Product
EptifibatideClinical trial
Impact of Early PCSK9 Inhibitor Treatment on Heart After Acute Myocardium Infarction： a Muti-center, Open-label, Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Product
alirocumabClinical trial
BEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic Function (BETAMI)Status: Active (not recruiting), Estimated PCD: 2024-12-10
Product
BetablockerClinical trial
Cardioprotection of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Angioplasty Through a Combined Antioxidant Therapy. A Phase I, Randomized Clinical Trial.Status: Completed, Estimated PCD: 2022-11-22
Product
Antioxidant therapyProduct
NaCl 0.9%Clinical trial
Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD): A Prospective, Multicenter, Randomized, Controlled TrialStatus: Recruiting, Estimated PCD: 2025-04-30
Product
Clopidogrel + AspirinProduct
AspirinClinical trial
Randomized Evaluation of Beta Blocker and Angiotensin Converting Enzyme Inhibitor (ACEI) /Angiotensin Receptor Blocker (ARB) Treatment in MINOCA Patients.Status: Terminated, Estimated PCD: 2023-05-31
Product
Beta blockerDrug
ACEIProduct
ARBClinical trial
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial InfarctionStatus: Not yet recruiting, Estimated PCD: 2025-05-01
Clinical trial
The Detection of Coronary Stenosis With Intravenous Mircrobubbles and Contrast Pulse Sequence Low Mechanical Index ImagingStatus: Withdrawn, Estimated PCD: 2013-03-01
Product
OptisonProduct
DefinityProduct
PESDAClinical trial
Cangrelor Versus Ticagrelor In Patients With Acute Myocardial Infarction Complicated With Initial Cardiogenic ShockStatus: Recruiting, Estimated PCD: 2024-01-01
Product
CangrelorProduct
TicagrelorClinical trial
Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction (DANBLOCK)Status: Recruiting, Estimated PCD: 2024-12-10
Product
Metoprolol SuccinateProduct
BisoprololProduct
NebivololClinical trial
Ivabradine for PREVENTion of Myocardial Injury After Noncardiac SurgeryStatus: Recruiting, Estimated PCD: 2025-03-15
Product
IvabradineDrug
VarlilumabClinical trial
A Comparative Study of Colchicine's Role in Reducing Cardiac Fibrosis in Acute Myocardial Infarction Patients: Evaluating Outcomes With Percutaneous Coronary Intervention Versus Without ReperfusionStatus: Completed, Estimated PCD: 2023-03-25
Product
ColchicineClinical trial
Prospective RandomizEd Study Comparing Glycoprotein IIb/IIIa Inhibitors VERsus Standard Therapy in patientS With Myocardial Infarction and Angiographic Evidence of No-reFLOWStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic CardiomyopathyStatus: Completed, Estimated PCD: 2010-12-01
Product
AtorvastatinClinical trial
Safety and Efficacy Evaluation of Umbilical Cord Mesenchymal Stem Cells Transcatheter Transplantation to Treat Left Ventricular Dysfunction After Acute Myocardial InfarctionStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Product
UC-MSCClinical trial
The Myocardial Infarction and New Treatment With Metformin Study (MIMET) - a R-RCT to Study Metformin and the Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Newly Detected PrediabetesStatus: Recruiting, Estimated PCD: 2026-05-01
Drug
MetforminClinical trial
PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery RevascularizationStatus: Completed, Estimated PCD: 2009-12-01
Product
ReteplaseClinical trial
Low-dose Dobutamine Infusion and Single-dose Tocilizumab in Acute Myocardial Infarction Patients With High Risk of Cardiogenic Shock Development - a 2x2 Multifactorial, Double-blinded, Randomized, Placebo Controlled TrialStatus: Recruiting, Estimated PCD: 2025-03-01
Drug
TocilizumabProduct
DobutamineClinical trial
Dapagliflozin Effects on Mayor Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction (DAPA-AMI). Randomized Clinical TrialStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
Randomized Evaluation of Decreased Usage of betablocCkErs After Myocardial Infarction in the SWEDEHEART Registry - A Registry-based, Randomized, Parallel, Open-label, Multicenter Trial (REDUCE-SWEDEHEART)Status: Active (not recruiting), Estimated PCD: 2023-11-16
Product
MetoprololClinical trial
Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE - a Randomized, Double-blind, Placebo-controlled, Trial (ELIMINATE Trial)Status: Recruiting, Estimated PCD: 2027-12-01
Product
Influenza vaccineClinical trial
A Single-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate Microvascular Disease After 12 Weeks of Therapy With Sodium-glucose Co-transporter 2 Inhibitor Compared to Placebo in Symptomatic Women With Non-obstructive Coronary Artery DiseaseStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention StudyStatus: Completed, Estimated PCD: 2020-01-17
Product
ClopidogrelDrug
AspirinClinical trial
Peri-tREatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index Measured by Cardiac maGnetic rEsonance Imaging in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary InterventionStatus: Recruiting, Estimated PCD: 2023-12-31
Product
SGLT2 inhibitorClinical trial
The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria RevascularizationStatus: Recruiting, Estimated PCD: 2024-03-31
Clinical trial
Outcomes of Low-dose Colchicine in Patients With Myocardial Infarction: A Randomized Controlled TrialStatus: Withdrawn, Estimated PCD: 2026-03-01
Clinical trial
Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction - A Prospective Single-centre, Single-arm Phase II StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Study to Evaluate the Safety of Reducing Dual Antiplatelet Therapy (DAPT) Duration to 1 Month for Patients With Acute Coronary Syndrome (ACS) After Implantation of Everolimus-eluting Cobalt-chromium StentStatus: Active (not recruiting), Estimated PCD: 2021-12-31
Product
1-months DAPTProduct
12-month DAPTClinical trial
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)Status: Recruiting, Estimated PCD: 2029-01-31
Product
StatinProduct
NexlizetProduct
LEQVIOProduct
VascepaProduct
JardianceClinical trial
The Effectiveness of Ranolazine in Reducing Cardiac Ischaemia Induced by Chronic Total Occlusions of Coronary ArteriesStatus: Withdrawn, Estimated PCD: 2016-12-01
Product
RanolazineClinical trial
Preventive and Personalized Medicine (2021-2023)Status: Completed, Estimated PCD: 2023-01-20
Clinical trial
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome: an Open-label Randomized TrialStatus: Recruiting, Estimated PCD: 2025-02-05
Clinical trial
Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction An Open-label, Single Center TrialStatus: Withdrawn, Estimated PCD: 2025-06-01
Product
AdenosineClinical trial
Phase III Study of Intravenous Glutamate Infusion for Metabolic Protection of the Heart in Surgery for Unstable Coronary Artery DiseaseStatus: Completed, Estimated PCD: 2009-12-01
Product
salineClinical trial
STunning in Acute Myocardial Infarction - Beta Blockers, Angiotensin Converting Enzyme Inhibitors and Sodium/Glucose Cotransporter 2 Inhibitors Trial A Low Intervention Clinical TriaStatus: Not yet recruiting, Estimated PCD: 2027-12-31